A near-autonomous AI chemist improves a challenging reaction in medicinal chemistry

OpenAI and Molecule.one report that a near-autonomous AI system using GPT-5.4 was able to improve a difficult reaction in medicinal chemistry that had resisted conventional optimization—a result that, if it holds up, would mark a meaningful step toward AI contributing substantive original work in drug synthesis rather than merely retrieving or summarizing existing knowledge. The claim merits careful scrutiny: the benchmark conditions, reproducibility, and degree of genuine autonomy versus scaffolded assistance all matter enormously before conclusions are drawn about what this represents. Still, the direction of travel—AI systems that can iterate experimentally in chemical space—carries real implications for how pharmaceutical research is organized and who does it.